Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 SEK)

Closing information 2022/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2 More Arrow 1,859 Less Arrow 503
Earnings before taxes -40,726 Less Arrow -52,142 More Arrow -44,240
EBITDA -40,724 Less Arrow -51,233 More Arrow -43,737
Total assets 36,679 More Arrow 52,786 Less Arrow 25,158
Current assets 33,650 More Arrow 50,717 Less Arrow 22,897
Current liabilities 6,526 Less Arrow 6,059 Less Arrow 4,520
Equity capital 30,153 More Arrow 46,727 Less Arrow 20,638
- share capital 2,557 More Arrow 27,448 Less Arrow 17,683
Employees (average) 5 Equal arrow 5 Less Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 82.2% More Arrow 88.5% Less Arrow 82.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -111.0% More Arrow -95.3% Less Arrow -173.8%
Current ratio 515.6% More Arrow 837.1% Less Arrow 506.6%
Return on equity (ROE) -135.1% More Arrow -111.6% Less Arrow -214.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 25% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.